Get the Stockscreener App
6.61
1.69%
0.11
After Hours:
6.59
-0.02
-0.30%
Lifecore Biomedical Inc stock is traded at $6.61, with a volume of 128.28K.
It is up +1.69% in the last 24 hours and down -12.10% over the past month.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
See More
Previous Close:
$6.50
Open:
$6.6
24h Volume:
128.28K
Relative Volume:
0.84
Market Cap:
$247.46M
Revenue:
$128.45M
Net Income/Loss:
$6.54M
P/E Ratio:
132.20
EPS:
0.05
Net Cash Flow:
$-8.79M
1W Performance:
-3.50%
1M Performance:
-12.10%
6M Performance:
+13.57%
1Y Performance:
+43.07%
1-Day Range:
$6.48
$7.0099
1-Week Range:
$6.44
$7.0099
52-Week Range:
$4.51
$8.85
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Name
Lifecore Biomedical Inc
Sector
Phone
(952) 368-4300
Address
3515 LYMAN BOULEVARD, CHASKA
Compare LFCR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
6.61 | 243.53M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
142.26 | 62.54B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 43.30B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.08 | 40.08B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.02 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.06 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-04-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-21-25 | Initiated | William Blair | Outperform |
| Sep-05-24 | Initiated | Craig Hallum | Buy |
| Aug-28-24 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-20-23 | Downgrade | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Stock (LFCR) Latest News
How high can Lifecore Biomedical Inc. stock go2025 EndofYear Setup & Community Consensus Stock Picks - newser.com
Best data tools to analyze Lifecore Biomedical Inc. stockPortfolio Risk Summary & Safe Swing Trade Setup Alerts - newser.com
Is it too late to sell Lifecore Biomedical Inc.2025 Key Lessons & Free Real-Time Market Sentiment Alerts - newser.com
What catalysts could drive Lifecore Biomedical Inc. stock higherWeekly Investment Report & Verified Swing Trading Watchlist - newser.com
Can Lifecore Biomedical Inc. stock beat market expectations this quarterSell Signal & Daily Oversold Stock Bounce Ideas - newser.com
3 Events: Lifecore to Present at PODD, CPHI Frankfurt & Pharma Outsourcing Summit Oct–Nov 2025 - Stock Titan
Will Lifecore Biomedical Inc. (LDE) stock deliver compounding returnsEarnings Recap Summary & Weekly Top Gainers Trade List - newser.com
Is it time to cut losses on Lifecore Biomedical Inc.2025 Momentum Check & Smart Money Movement Tracker - newser.com
Will Lifecore Biomedical Inc. bounce back from current supportQuarterly Earnings Summary & High Yield Stock Recommendations - newser.com
Chart overlay techniques for tracking Lifecore Biomedical Inc.2025 Geopolitical Influence & Community Verified Trade Signals - newser.com
How Lifecore Biomedical Inc. (LDE) stock compares with market leadersTrade Entry Report & Fast Exit and Entry Strategy Plans - newser.com
Analyzing net buyer seller activity in Lifecore Biomedical Inc.2025 Risk Factors & Weekly Hot Stock Watchlists - newser.com
With 45% stake, Lifecore Biomedical, Inc. (NASDAQ:LFCR) seems to have captured hedge funds investors' interest - Yahoo Finance
Rating Downgrade: Lifecore, Ready To Go, But Problems Remain (NASDAQ:LFCR) - Seeking Alpha
CEO Insights: Industry Trends Driving Strong Tailwinds for U.S.-based CDMOs - Contract Pharma
Using fundamentals and technicals on Lifecore Biomedical Inc.Swing Trade & Weekly Watchlist for Hot Stocks - newser.com
Why pension funds invest in Lifecore Biomedical Inc. (LDE) stockMarket Growth Report & Reliable Price Breakout Alerts - newser.com
Real time alert setup for Lifecore Biomedical Inc. performanceQuarterly Earnings Summary & Community Consensus Stock Picks - newser.com
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Published on: 2025-10-05 05:34:33 - newser.com
Lifecore granted Sector Weight rating at KeyBanc on growth trajectory - MSN
Can volume confirm reversal in Lifecore Biomedical Inc.Market Trend Report & AI Driven Price Forecasts - newser.com
Is Lifecore Biomedical Inc. (LDE) stock suitable for passive index funds2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
Quantitative breakdown of Lifecore Biomedical Inc. recent moveOil Prices & Real-Time Stock Entry Alerts - newser.com
LIFECORE SHAREHOLDER ALERT: Kaskela Law LLC Announces - GlobeNewswire
What drives Lifecore Biomedical Inc stock priceStock Buy Signals & Big Returns, Small Investment – Learn How - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Lifecore Biomedical Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView
What analysts say about Lifecore Biomedical Inc LDE stockStraddle and Strangle Trades & Free Stock Education Platform for New Investors - earlytimes.in
What analysts say about Lifecore Biomedical Inc stockMarket Correction Analysis & High Profit Market Growth - earlytimes.in
Is Lifecore Biomedical Inc a good long term investmentTechnical Analysis Insights & Learn to Trade with Real-Time Feedback - earlytimes.in
What drives Lifecore Biomedical Inc LDE stock priceEx-Dividend Date Alerts & Small Budget Trading Plans - earlytimes.in
Lifecore Biomedical Inc Stock (LFCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lifecore Biomedical Inc Stock (LFCR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| English Aron R. | 10% Owner |
May 28 '25 |
Sale |
7.12 |
150,419 |
1,071,555 |
264,180 |
| English Aron R. | 10% Owner |
May 23 '25 |
Sale |
6.75 |
96,137 |
649,386 |
1,554,103 |
| English Aron R. | 10% Owner |
May 13 '25 |
Sale |
7.00 |
12,334 |
86,353 |
1,650,240 |
| English Aron R. | 10% Owner |
May 12 '25 |
Sale |
7.03 |
45,698 |
321,426 |
1,662,574 |
| English Aron R. | 10% Owner |
May 08 '25 |
Sale |
7.00 |
5,098 |
35,693 |
1,708,972 |
| English Aron R. | 10% Owner |
May 09 '25 |
Sale |
7.00 |
700 |
4,900 |
1,708,272 |
| English Aron R. | 10% Owner |
May 05 '25 |
Sale |
7.08 |
24,543 |
173,831 |
1,730,618 |
| English Aron R. | 10% Owner |
May 07 '25 |
Sale |
7.01 |
15,847 |
111,099 |
1,714,070 |
| English Aron R. | 10% Owner |
May 06 '25 |
Sale |
7.05 |
701 |
4,940 |
1,729,917 |
| Josephs Paul | Chief Executive Officer |
Jan 08 '25 |
Buy |
5.74 |
17,000 |
97,580 |
559,717 |
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):